Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ketamine (ketalar) (1 trial)
Depression (Phase 1)
Depressive Disorder (Phase 1)
Depressive Disorder, Major (Phase 1)
Disease (Phase 1)
Trials (1 total)
Trial APIs (1 total)